Pharmacological induced Anxiety Mouse Model Development Service
Are you currently facing challenges in translating preclinical anxiolytic hits to clinical success, often due to confounding sedative effects or models lacking predictive validity? Our Pharmacological-Induced Anxiety Mouse Models Development Services help you accelerate drug discovery and obtain clear, non-confounded efficacy data. This is achieved through rapid, high-throughput screening platforms and our commitment to advanced, translational physiological biomarkers, ensuring your therapeutic candidates are validated against the highest industry standards.
How Our Pharmacological-Induced Anxiety Mouse Models Development Services Can Assist Your Project
Our service provides a clear, highly systematic pathway for the rapid validation of your novel anxiolytic compounds, grounded in real-world translational science.
Discover How We Can Help - Request a Consultation
Workflow: Precision Screening from Concept to Report
We provide a comprehensive and detailed explanation for each point in the workflow, suitable for visualization as a flowchart, making it very clear to potential clients what is involved.
| Required Starting Materials |
|
| Final Deliverables |
|
Why Choose Us?
At Creative Biolabs, our commitment to Quality-by-Design (QbD) and translational rigor sets our pharmacological-induced anxiety mouse models development services apart. We offer a level of specificity and control unparalleled in preclinical screening, ensuring your data is clean, robust, and clinically relevant.
Key Advantages and Unique Features
- Targeted Pathway Specificity: We move beyond generalized anxiety models by using agents like m-Chlorophenylpiperazine (mCPP) to specifically challenge the 5–HT2C pathway, allowing direct testing of serotonergic-targeted drugs.
- Zero-Tolerance for Confounding Effects: Our standard protocol integrates Rotarod and Tail Suspension Test (TST) controls, guaranteeing that any observed anxiolytic effect is not a false positive caused by motor sedation or anti-depressant activity.
- Translational Biomarker Integration: We routinely use Stress-Induced Hyperthermia (SIH) as a conserved physiological readout, providing objective evidence of HPA axis moderation—a key step towards human translation.
- QbD-Driven Reproducibility: Every protocol adheres to Quality-by-Design principles, ensuring low inter-subject variability, high data integrity, and superior reproducibility compared to models lacking formal quality controls.
Experience the Advantage - Get a Quote Today
Pharmacological-Induced Anxiety Mouse Models
This section details the core scientific methodology behind the service, highlighting its precision in modeling acute anxiety states.
- The Power of State Anxiety Induction
PAMM utilizes rapid-acting anxiogenic compounds or procedures to induce a temporary, yet pronounced, state of heightened anxiety. This approach is superior for early drug screening as it provides fast, reliable, and targeted results. For example, our use of mCPP—a 5–HT2C partial agonist—is highly effective for rapidly inducing a transient, severe anxiety phenotype that directly links to the central serotonergic system.
- Gold-Standard Behavioral Phenotyping
Precise behavioral assessment is the cornerstone of PAMM validity. Our platform employs a tri-panel approach, utilizing automated video tracking systems for objective, high-resolution data capture based on the ethological principle of approach-avoidance conflict:
| Behavioral Assay | Primary Readout & Principle | Validation Focus |
| Elevated Plus Maze (EPM) | Time spent and entries into open arms (approach-avoidance conflict) | Measures natural aversion to open, elevated spaces. |
| Light/Dark Box (LDB) | Time spent in the light compartment and transitions between compartments | Measures innate aversion to brightly lit, exposed environments. |
| Open Field Test (OFT) | Total distance traveled and time spent in the center | Crucially serves as the control for locomotor activity. |
What We Can Offer
We provide end-to-end support for your anxiolytic program, from discovery screening to deep translational validation.
High-Throughput Screening Packages:
Leverage our validated PAMM protocols (mCPP, Pentylenetetrazol (PTZ), etc.) combined with core behavioral assessments (EPM, LDB, OFT) for fast, reliable compound activity determination.
Related Services
To further support your psychotropic drug development goals, CBL offers several complementary services that integrate seamlessly with our PAMM platform.
- Target Identification & Validation
- Compound Screening & Profiling
- Pharmacokinetic/Pharmacodynamic (PK/PD) Studies
- Neuroinflammation Research Models
FAQs
Q Why should I choose PAMM over chronic stress models like CUMS for my screening?
Q How do you guarantee the anxiolytic effects you measure are not merely due to sedation?
For more information and to discuss how our services can meet your specific project requirements, please contact our team of experts.
Contact Our Team for More Information and to Discuss Your Project.
- iNeuMab™ Mouse Anti-LRP1 Monoclonal Antibody (CBP3363) (Cat#: NAB-0720-Z6479)
- iNeuMab™ Anti-F-Spondin/SPON1 Antibody, Clone 3F4 (Cat#: NRZP-0822-ZP4740)
- iNeuMab™ Rabbit Anti-Alpha-synuclein (CBP1631) (Cat#: NAB-08-PZ079)
- Mouse Anti-Human α-Synuclein Phospho (Tyr39) (CBP3706) (Cat#: NAB201250LS)
- Mouse Anti-SCN5A Monoclonal Antibody (CBP708) (Cat#: NAB-0720-Z2720)
- iNeuMab™ Rabbit Anti-LRRK2 Monoclonal Antibody (CBP1887) (Cat#: NAB-08-PZ735)
- iNeuMab™ Mouse Anti-EFNB2 Monoclonal Antibody (CBP1159) (Cat#: NAB-0720-Z4396)
- iNeuMab™ Mouse Anti-SHANK3 Monoclonal Antibody (CBP929) (Cat#: NAB-0720-Z3477)
- iNeu™ Human Motor Neurons (Cat#: NCL-2103-P71)
- Mouse Retinal Ganglion Cell Line RGC-5 (Cat#: NCL2110P154)
- Rat Glioma Cell Line C6 (Cat#: NCL2110P346)
- Mouse Glioma Cell Line GL-261-Luc (Cat#: NCL-2108P06)
- Mouse Glioma Cell Line GL261-GFP (Cat#: NCL-2108P04)
- Human Astrocytes, Immortalized (Cat#: NCL-2105-P182-AM)
- iNeu™ Human Neural Stem Cell Line (Cat#: NCL200552ZP)
- Rat Microglia Cell Line HAPI, Immortalized (Cat#: NCL2110P015)
- Human Blood Brain Barrier Model (Cat#: NCL-2103-P187)
- Immortalized Human Cerebral Microvascular Endothelial Cells (Cat#: NCL-2108-P020)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- ABCA1 Antisense Oligonucleotide (NV-2106-P27) (Cat#: NV-2106-P27)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- Human apolipoprotein E (APOE) (NM_000041) ORF clone, Untagged (Cat#: NEP-0421-R0232)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP510)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-idursulfase BBB Shuttle Protein (Cat#: NRZP-0423-ZP497)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP500)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)
